Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study.
Journal: Breast cancer (Tokyo, Japan)
Published: March 29, 2024
Machine Learning Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy for ER+HER2- Breast Cancer: Integrating Tumoral and Peritumoral MRI Radiomic Features.
Journal: Diagnostics (Basel, Switzerland)
Published: September 05, 2023
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Journal: Breast cancer research and treatment
Published: July 14, 2023
Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea.
Journal: Palliative medicine reports
Published: December 13, 2022
Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA.
Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA.
Journal: Nature communications
Published: July 20, 2022
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 18, 2022
Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 30, 2021
Last Updated: 09/26/2026